Panel Discussion: What’s next for the bioanalysis of biopharmaceuticals and biomarkers?
In this panel discussion our experts analyze the results from our recent survey on the bioanalysis of biopharmaceuticals and biomarkers, providing a comprehensive overview and focusing on the developing technologies and trends.
You will also have the opportunity to pose your questions for our experts to address in the live Q & A session. Submit your question ahead of time here!
What will you learn?
- Results from our recent survey on the bioanalysis of biopharmaceuticals and biomarkers
- What applications people currently use for biopharmaceuticals and biomarkers bioanalysis
- Advantages and challenges of biomarker analysis and of technologies used for assessing product quality
- Latest techniques including microflow LC–MS and signature peptide approach
- Future developments
Who may this interest?
- CRO’s, pharmaceutical and biotechnology companies
- Bioanalytical scientists
- Biomarker scientists
